Abstract
摘要
相似文献
1
New drug information. Saphris.
JAAPA. 2010 Mar;23(3):16.
2
Asenapine (Saphris) sublingual tablets for schizophrenia and bipolar disorder.
Med Lett Drugs Ther. 2010 Feb 8;52(1331):9-10.
3
Asenapine.
Nat Rev Drug Discov. 2009 Nov;8(11):843-4. doi: 10.1038/nrd3027.
4
ACS chemical neuroscience molecule spotlight on Saphris.
ACS Chem Neurosci. 2010 Apr 21;1(4):263-4. doi: 10.1021/cn100022a.
5
Asenapine review, part II: clinical efficacy, safety and tolerability.
Expert Opin Drug Saf. 2014 Jun;13(6):803-30. doi: 10.1517/14740338.2014.908183. Epub 2014 May 3.
6
Update on newer antipsychotic drugs.
J Psychosoc Nurs Ment Health Serv. 2011 Apr;49(4):13-5. doi: 10.3928/02793695-20110311-99. Epub 2011 Mar 30.
7
Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania.
Drugs Today (Barc). 2009 Dec;45(12):865-76. doi: 10.1358/dot.2009.45.12.1421561.
8
Asenapine approved for treatment of schizophrenia, bipolar disorder.
Am J Health Syst Pharm. 2009 Sep 15;66(18):1596. doi: 10.2146/news090073.
9
New drugs: asenapine, iloperidone, and bepotastine besilate.
J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):107-10. doi: 10.1331/JAPhA.2010.10505.
10
Paradoxical pinpoint pupils with asenapine.
Asia Pac Psychiatry. 2015 Jun;7(2):230. doi: 10.1111/appy.12171.
Zotero 插件